FDA Inspection 1314324 — UCLA Health, UCLA Blood & Platelet Center

UCLA Health, UCLA Blood & Platelet Center — FEI 3004048013

The FDA completed an inspection of UCLA Health, UCLA Blood & Platelet Center on April 15, 2026 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 15, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Los Angeles, CA (United States)